Day: January 28, 2025

Ascot Resources Provides Update on CEO Review and Postpones Scheduled Conference Call

Written by Customer Service on January 28, 2025. Posted in Public Companies.

VANCOUVER, British Columbia, Jan. 28, 2025 (GLOBE NEWSWIRE) — Ascot Resources Ltd. (TSX: AOT; OTCQX: AOTVF) (“Ascot” or the “Company”) announces that the Company’s newly appointed President and Chief Executive Officer, Jim Currie and his new management team, are continuing a detailed review and assessment of Ascot’s mining operations and overall business strategy. Given the significance and complexity of this process, Mr. Currie requires additional time to complete his evaluation. As a result, the previously scheduled conference call, announced in the Company’s January 15, 2025 press release, has been postponed. The Company will announce a new date for the conference call in a subsequent press release once Mr. Currie has completed his review and is prepared to provide a comprehensive update to stakeholders. “It is critical to ensure...

Transocean Ltd. Announces Fourth Quarter, Full Year 2024 Earnings Release Date

Written by Customer Service on January 28, 2025. Posted in Public Companies.

STEINHAUSEN, Switzerland, Jan. 28, 2025 (GLOBE NEWSWIRE) — Transocean Ltd. (NYSE: RIG) announced today that it will report earnings for the fourth quarter and full year 2024 on Monday, February 17, 2025. The company will conduct a teleconference to discuss the results starting at 9 a.m. EST, 3 p.m. CET, on Tuesday, February 18, 2025. Individuals who wish to participate should dial +1 785-424-1116 approximately 15 minutes prior to the scheduled start time and refer to conference code 540196. The teleconference will be simulcast in a listen-only mode at: www.deepwater.com, by selecting Investors, News, and Webcasts. A replay of the conference call will be available after 12 p.m. EST, 6 p.m. CET, on February 18, 2025. The replay, which will be archived for approximately 30 days, can be accessed at +1 402-220-1152, passcode 540196....

Finward Bancorp Announces Earnings for the Quarter and Twelve Months Ended December 31, 2024

Written by Customer Service on January 28, 2025. Posted in Earnings Releases And Operating Results.

MUNSTER, Ind., Jan. 28, 2025 (GLOBE NEWSWIRE) — Finward Bancorp (Nasdaq: FNWD) (the “Bancorp”), the holding company for Peoples Bank (the “Bank”), today announced that net income available to common stockholders was $12.1 million, or $2.84 per diluted share, for the twelve months ended December 31, 2024, as compared to $8.4 million, or $1.96 per diluted share, for the corresponding prior year period. For the three months ended December 31, 2024, the Bancorp’s net income totaled $2.1 million, or $0.49 per diluted share, as compared to $606 thousand, or $0.14 per diluted share, for the three months ended September 30, 2024, and as compared to $1.5 million, or $0.35 per diluted share, for the three months ended December 31, 2023. Selected performance metrics are as follows for the periods presented:Performance Ratios Quarter...

Stifel Raises Quarterly Common Stock Cash Dividend by 10% and Declares Preferred Stock Cash Dividend

Written by Customer Service on January 28, 2025. Posted in Dividend Reports And Estimates.

ST. LOUIS, Jan. 28, 2025 (GLOBE NEWSWIRE) — Stifel Financial Corp. (NYSE: SF) today announced that its Board of Directors has declared a cash dividend on shares of its common stock of $0.46 per share, payable March 17, 2025, to shareholders of record at the close of business on March 3, 2025. The Board of Directors also declared a quarterly cash dividend on the outstanding shares of its 6.25% Non-Cumulative Perpetual Preferred Stock, Series B (the “Series B Preferred Stock”), 6.125% Non-Cumulative Perpetual Preferred Stock, Series C (the “Series C Preferred Stock”), and 4.50% Non-Cumulative Perpetual Preferred Stock, Series D (the “Series D Preferred Stock”). The declared cash dividend on the Series B Preferred Stock, Series C Preferred Stock, and Series D Preferred Stock is for the period from December 16, 2024, up to, but excluding,...

STERIS Declares Dividend of $0.57 per share

Written by Customer Service on January 28, 2025. Posted in Dividend Reports And Estimates.

DUBLIN, IRELAND, Jan. 28, 2025 (GLOBE NEWSWIRE) — STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that the Company will distribute a quarterly interim dividend of $0.57 per share. The dividend is payable on March 21, 2025, to shareholders of record at the close of business on February 20, 2025. Additional information about the U.S. tax treatment of dividends, including required Forms 8937, is available at www.steris-ir.com. STERIS is a leading global provider of products and services that support patient care with an emphasis on infection prevention. WE HELP OUR CUSTOMERS CREATE A HEALTHIER AND SAFER WORLD by providing innovative healthcare and life sciences products and services around the globe. Company Contact: Julie Winter, Vice President, Investor Relations and Corporate Communications Julie_Winter@steris.com +1.440.392.7245 CAUTIONARY...

First Commonwealth Announces Fourth Quarter and Full Year 2024 Earnings; Declares Quarterly Dividend

Written by Customer Service on January 28, 2025. Posted in Dividend Reports And Estimates.

INDIANA, Pa., Jan. 28, 2025 (GLOBE NEWSWIRE) — First Commonwealth Financial Corporation (NYSE: FCF) today announced financial results for the fourth quarter and full year of 2024. Financial Summary(dollars in thousands, For the Three Months Ended For the Year Endedexcept per share data) December 31, September 30, December 31, December 31, December 31, 2024 2024 2023 2024 2023Reported Results Net income $ 35,849 $ 32,086 $ 44,827 $ 142,572 $ 157,063 Diluted earnings per share $ 0.35 $ 0.31 $ 0.44 $ 1.39 $ 1.54 Return on average assets 1.23 % 1.08 % 1.56 % 1.22 % 1.42 %Return on average equity 10.16 % 9.19 % 14.11 % 10.44 % 12.80 % Operating Results (non-GAAP)(1) Core...

23andMe Special Committee Announces Exploration of Strategic Alternatives

Written by Customer Service on January 28, 2025. Posted in Public Companies.

SUNNYVALE, Calif., Jan. 28, 2025 (GLOBE NEWSWIRE) — The Special Committee of the Board of Directors of 23andMe Holding Co. (Nasdaq: ME) (“23andMe” or the “Company”), a leading human genetics company with a mission to help people access, understand, and benefit from the human genome, today announced that it has undertaken a process to explore strategic alternatives, including, among other alternatives, a possible sale of the company, business combination, sale of all or part of the Company’s assets, licensing of assets, restructuring, or other strategic action. The Board of Directors of 23andMe previously formed the Special Committee, which is comprised of independent directors, to review strategic alternatives that may be available to 23andMe. The Special Committee has engaged Moelis & Company LLC as its financial advisor...

First Central Savings Bank Reports Fourth Quarter 2024 net income of $2.0 million ($0.19 EPS), Significant Non-Interest Income Growth Quarter over Quarter, and Special Cash Dividend of $0.15 per share

Written by Customer Service on January 28, 2025. Posted in Earnings Releases And Operating Results.

Performance HighlightsNet Income: Net income for the quarter ended December 31, 2024, was $2.0 million or $0.19 per share, compared to $919 thousand or $0.09 per share, recorded in the prior linked quarter and $1.3 million or $0.12 per share, in the comparable 2023 quarter. Cash Net Income: Cash net income for the quarter ended December 31, 2024, was $2.2 million or $0.21 per share, compared to $1.9 million or $0.18 per share, recorded in the prior quarter and $1.5 million or $0.14 per share, in the comparable 2023 quarter Significant Non-Interest Income Growth: Due to an increase in loan sale volume and loan sale premiums received for the quarter ended December 31, 2024, non-interest income increased by $1.0 million or 53.4% from the prior linked quarter and were up $1.5 million or 106.6% from the prior year quarter. Net Interest Income:...

NeuroPace Issues 2025 Financial Guidance Targets

Written by Customer Service on January 28, 2025. Posted in Public Companies.

– 2025 revenue guidance of $92 million to $96 million – – 2025 gross margin guidance of 73% to 75% – – Three-year targets of 20% revenue CAGR and achievement of cash flow breakeven – MOUNTAIN VIEW, Calif., Jan. 28, 2025 (GLOBE NEWSWIRE) — NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today issued 2025 financial guidance targets at an in-person and virtual Investor Day today in New York, New York (a replay can be viewed virtually here, and the accompanying slide presentation can be accessed here). 2025 Financial Guidance and Three-Year Strategic Objectives NeuroPace provided initial financial guidance targets for 2025:Revenue of $92 million – $96 million, representing growth of 15.5% – 20.5% versus the midpoint of the expected 2024 revenue range of $79.4...

23andMe Reports Third Quarter Fiscal Year 2025 Financial Results

Written by Customer Service on January 28, 2025. Posted in Earnings Releases And Operating Results.

Company Notes Continued Concerns Regarding Liquidity and Consideration of Potential Ways to Address Operational and Financial Challenges SUNNYVALE, Calif., Jan. 28, 2025 (GLOBE NEWSWIRE) — 23andMe Holding Co. (Nasdaq: ME) (“23andMe,” the “Company,” “we,” “us,” and “our”), a leading human genetics company with a mission to help people access, understand, and benefit from the human genome, reported its financial results for the third quarter (“Q3”) of fiscal year 2025 (“FY25”), which ended December 31, 2024. Notable Items in Q3 of FY25We recognized $19.3 million of non-recurring research services revenue pursuant to the 2023 GSK Amendment. This revenue represents substantially all remaining revenue associated with the 2023 GSK Amendment. We received the cash associated with this revenue in Q3 of FY24. Consumer Services Revenue...

Day: January 28, 2025

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals